Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) — Boston, Massachusetts

Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) has participated in 2 clinical trials.

Therapeutic areas: Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Non-Small Cell Lung Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boston

Browse all research sites in Massachusetts · View every site in Boston

• Massachusetts General Hospital Translational and Clinical Research Center
• Boston VA CSP Coordinating Center
• Boston Children's Hospital / Dana Farber Cancer Institute / Massachusetts General Hospital
• Massachusetts General Hospital Site Number : 002
• Laboratories of Cognitive Neuroscience, Boston Children's Hospital
• The Brigham and Women's Hospital Department of Anesthesiology
• Tuft University Hospital
• Boston Children's Hospital /ID# 162863
• Dana Farber Cancer Institute/Children's Hospital of Boston
• Brigham and Women's Hospital
• Brigham & Woman's Hospital/Boston
• Caritus St. Elizabeth's Hospital

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203)?

Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) conducted?

Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) has 2 clinical trials on record. Their work covers Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Non-Small Cell Lung Cancer.

Is Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) accredited by Crixeo Clinical Trials?

Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital-Cancer Center Protocol Office ( Site 0203)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.